Rx Savings' Rea on Mylan Under Scrutiny for EpiPen Price(Audio)
Aug 24, 2016
08:00
forum Ask episode
view_agenda Chapters
auto_awesome Transcript
info_circle Episode notes
(Bloomberg) -- Taking Stock with Kathleen Hays and Pimm Fox. GUEST: Michael Rea, CEO of Rx Savings Solutions, to discuss Mylan's EpiPen price hike, currently under scrutiny.
